Gene Biotherapeutics, Inc.

For profitWebsite ↗

Also known as: Cardium Therapeutics, 12255 El Camino Real #250, San Diego, CA 92130, (858) 436-1000 | Cardium Therapeutics, 12255 El Camino Real, Suite 250, San Diego, CA 92130, USA, +1-858-436-1000

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

Jun 1, 2003

Last known activity

Mar 1, 2012

Timeline

2000s

Jun 1, 2003
Gene Biotherapeutics, Inc.— Founded
Mar 9, 2006
Innercool Therapies— Acquired
Aug 11, 2006
Tissue Repair Company— Acquired

Drugs by trial phase (2 distinct, 6 trials)

Phase 3 (1 own, 0 via acquisition)

alferminogene tadenovec

Phase 2 (0 own, 1 via acquisition)

gam501

Indications

Studied for

Subsidiaries (2 direct, 2 total across the full acquisition tree)

Recent trials (9)

NCT01550614Study directorPhase 3Mar 1, 2012
NCT01550614Lead sponsorPhase 3Mar 1, 2012
NCT00493051CollaboratorPhase 2Nov 1, 2007
NCT00438867Study directorPhase 3May 1, 2007
NCT00438867Lead sponsorPhase 3May 1, 2007
NCT00185263Lead sponsorPhase 2/Phase 3Mar 1, 2002
NCT00185263Study directorPhase 2/Phase 3Mar 1, 2002
NCT00346437Lead sponsorPhase 2/Phase 3Oct 1, 2001
NCT00346437Study directorPhase 2/Phase 3Oct 1, 2001

Details

Founded: San Diego, CA, US Jun 1, 2003
Last known activity: Mar 1, 2012

Notes

formerly Cardium Therapeutics - SECURED SOME FUNDING IN 2020 DELIST IN 2022 IF NO FURTHER EVIDENCE OF PROGRESS